Acadia Pharmaceuticals buy Mizuho
Start price
29.12.23
/
50%
€28.40
Target price
29.12.24
€36.19
Performance (%)
-39.37%
Price
30.07.24
€17.22
Summary
This prediction is currently active. The BUY prediction by Mizuho for Acadia Pharmaceuticals is performing very badly with a performance of -39.37%. This prediction currently runs until 29.12.24. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 5.579% | 5.579% |
iShares Core DAX® | -0.621% | 1.080% |
iShares Nasdaq 100 | -4.503% | -5.432% |
iShares Nikkei 225® | -2.562% | -1.617% |
iShares S&P 500 | -1.706% | -1.223% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Mizuho from $35.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€36.02
28.02.25
28.02.25
-20.28%
30.07.24
30.07.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.40
06.11.23
06.11.23
€32.59
06.11.24
06.11.24
-23.13%
30.07.24
30.07.24